Nasdaq
RLMD
Relmada Therapeutics, Inc.
- Health Care
- 1 day
- −1.3%
- 1 month
- −16.2%
- 1 year
- +796%
$5.37 · Mkt cap $563M
At the 6 Aug 2026 close
Nasdaq
Relmada Therapeutics, Inc.
$5.37 · Mkt cap $563M
At the 6 Aug 2026 close
Relmada Therapeutics, Inc. trades under the ticker RLMD on Nasdaq, in the Health Care sector (Biotechnology: Pharmaceutical Preparations). Its market capitalisation is $563M. The last closing price was $5.37, on 6 Aug 2026. No price-to-earnings ratio is shown, because it did not report positive earnings in its last annual filing. Over the past year the share price is +796%, and −16.2% over the past month. Returns are price returns and exclude dividends.
This page exists because RLMD is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.